-
VHSD
Viral Hepatitle Savaşım Derneği
J Immunol. 2015 Jan 15;194(2):690-6. doi: 10.4049/jimmunol.1401659. Epub
2014 Dec 12.
The effects of cytokines on spontaneous hepatitis B surface antigen seroconversion in chronic hepatitis B virus infection.
Wu JF1, Hsu HY1, Chiu YC1, Chen HL2, Ni YH3, Chang MH4.Author information
Abstract
We examined the role of human cytokines in the natural course of hepatitis B surface Ag (HBsAg) seroconversion in chronic hepatitis B virus (HBV) infection. The clinical course of spontaneous HBsAg seroconversion was assessed in 296 chronically HBV-infected patients. Single nucleotide polymorphisms (SNPs) in IL-1ß, IL-2, IL-4, IL-10, IL-12ß, IL-13, IL-27, and IFN-? genes were examined in 296 chronically HBV-infected patients and another 193 HBV recoverers. The HBsAg a determinant sequence of chronically HBV-infected subjects with and without HBsAg seroconversion was also analyzed. The start of the immune-clearance phase (serum alanine aminotransferase levels > 30 IU/l) before the age of 48 mo and hepatitis B e Ag (HBeAg) seroconversion before the age of 10 y predicted spontaneous HBsAg seroconversion in chronically HBV-infected patients (odds ratios 17.7 and 5.0; p < 0.001 and p < 0.002, respectively). The A-allele of IL-10 SNP
rs1800872 was associated with higher IL-10 serum levels, and the G-allele of IL-12ß SNP rs3212217 was associated with sustained high serum IL-12p70 levels during the immune-clearance phase. Both were predictors of spontaneous HBsAg seroconversion and HBV recovery (odds ratios 4.0 and 26.3; p = 0.002 and p < 0.001, respectively). Spontaneous HBsAg seroconversion was not related to sex, HBV genotype, or HBsAg a determinant mutation. The start of immune-clearance phase, age at HBeAg seroconversion, and serum IL-10 and
IL-12 levels are associated with the course of the immune-clearance phase in chronic HBV infection, and are predictive of spontaneous HBsAg seroconversion and HBV recovery.
Copyrights © 2017-2023 All Rights Reserved. Powered by vhsd.org
Kişisel Verilerin Korunması Kanununu
Web sitemizin içeriği, ziyaretçiyi bilgilendirmeye yönelik hazırlanmıştır. Sitede yer alan bilgiler, hiçbir zaman bir hekim tedavisinin ya da konsültasyonunun yerini alamaz. Bu kaynaktan yola çıkarak, ilaç tedavisine başlanması ya da mevcut tedavinin değiştirilmesi kesinlikte tavsiye edilmez. Web sitemizin içeriği, asla kişisel teşhis ya da tedavi yönteminin seçimi için değerlendirilmemelidir. Sitede kanun içeriğine aykırı ilan ve reklam yapma kastı bulunmamaktadır.© 2017 - 2023, Tüm hakları saklıdır. Gizlilik Sözleşmesi. Bu web sitesi CEOTECH tarafından yapılmıştır. Daha detaylı bilgi almak için lütfen tıklayınız.